<ul><li>AI is revolutionizing drug discovery by utilizing vast datasets and AI-driven approaches to identify promising drug candidates and predict their efficacy.</li><li>AlphaFold 3, powered by machine learning and neural networks, revolutionizes drug discovery by accurately predicting 3D molecular structures and guiding researchers to viable candidates faster.</li><li>AI has already shown real-world impact in designing mRNA vaccine sequences, discovering novel antibiotics, and speeding up drug development processes.</li><li>Despite facing challenges related to data quality, ethics, and regulations, AI in drug discovery is projected to continue advancing, driving personalized medicine and leading to the first fully AI-designed drug gaining FDA approval by 2026.</li></ul>

How AI Is Revolutionizing Drug Discovery in 2025- with Alphafold 3

Discover more